158 related articles for article (PubMed ID: 21051168)
1. Chronic anemia resistant to erythropoietin in a patient treated with gemcitabine showing a hemolytic uremic syndrome (HUS).
Assi C; Lepage C; Jouve JL; Sgro C; Bedenne L
Gastroenterol Clin Biol; 2010 Nov; 34(11):640-2. PubMed ID: 21051168
[No Abstract] [Full Text] [Related]
2. Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.
Lee HW; Chung MJ; Kang H; Choi H; Choi YJ; Lee KJ; Lee SW; Han SH; Kim JS; Song SY
Gut Liver; 2014 Jan; 8(1):109-12. PubMed ID: 24516709
[TBL] [Abstract][Full Text] [Related]
3. [Is the frequency of hemolytic uremic syndrome as a complication of gemcitabine underestimated? The role of systematic screening].
Desramé J; Duvic C; Béchade D; Bredin C; Raynaud JJ; Defuentes G; Dourthe LM; Algayres JP
Gastroenterol Clin Biol; 2006 Feb; 30(2):332-4. PubMed ID: 16565677
[No Abstract] [Full Text] [Related]
4. [A case of hemolytic uremic syndrome after adjuvant chemotherapy with gemcitabine in a patient with pancreatic cancer].
Wato M; Inaba T; Ishikawa H; Ishikawa S; Baba N; Miyoshi M; Senoh T; Nagano T; Takaguchi K; Watanabe S; Kawai K
Nihon Shokakibyo Gakkai Zasshi; 2010 Oct; 107(10):1676-85. PubMed ID: 20938119
[TBL] [Abstract][Full Text] [Related]
5. Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.
Saif MW; McGee PJ
JOP; 2005 Jul; 6(4):369-74. PubMed ID: 16006690
[TBL] [Abstract][Full Text] [Related]
6. [Hemolytic uremic syndrome induced by gemcitabine. A poorly recognized complication?].
Graas MP; Houbiers G; Demolin G; Stultiens A; Focan C
Rev Med Liege; 2012 Dec; 67(12):644-8. PubMed ID: 23342875
[TBL] [Abstract][Full Text] [Related]
7. Haemolytic uraemic syndrome after gemcitabine treatment for pancreatic carcinoma.
Choi M; Woywodt A; Göbel U; Schneider W; Kettritz R
Nephrol Dial Transplant; 1999 Oct; 14(10):2523-4. PubMed ID: 10528696
[No Abstract] [Full Text] [Related]
8. [Hemolytic-uremic syndrome associated with gemcitabine use: report of one case].
Vega J; Parodi C; Méndez GP; Goecke H
Rev Med Chil; 2013 Jun; 141(6):797-802. PubMed ID: 24121585
[TBL] [Abstract][Full Text] [Related]
9. [Hemolytic uremic syndrome following gemcitabine treatment].
Bourquin V; Guinand A; Haenni C; Giovannini M; Delouche D; Dettwiler S; Moll S
Rev Med Suisse; 2008 Apr; 4(154):1056-61. PubMed ID: 18557535
[TBL] [Abstract][Full Text] [Related]
10. Gemcitabine and haemolytic-uraemic syndrome.
Ruiz I; Del Valle J; Gómez A
Ann Oncol; 2004 Oct; 15(10):1575-6. PubMed ID: 15367421
[No Abstract] [Full Text] [Related]
11. Gemcitabine-induced hemolytic uremic syndrome: a case report.
Brodowicz T; Breiteneder S; Wiltschke C; Zielinski CC
J Natl Cancer Inst; 1997 Dec; 89(24):1895-6. PubMed ID: 9414181
[No Abstract] [Full Text] [Related]
12. Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma.
Nieto-Ríos JF; Zuluaga-Quintero M; Higuita LM; Rincón CI; Galvez-Cárdenas KM; Ocampo-Kohn C; Aristizabal-Alzate A; Florez-Vargas AA; Zuluaga-Valencia GA
J Bras Nefrol; 2016 Jun; 38(2):255-9. PubMed ID: 27438981
[TBL] [Abstract][Full Text] [Related]
13. Rituximab to treat gemcitabine-induced hemolytic-uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review.
Ritchie GE; Fernando M; Goldstein D
Cancer Chemother Pharmacol; 2017 Jan; 79(1):1-7. PubMed ID: 27497971
[TBL] [Abstract][Full Text] [Related]
14. [A 42-year-old patient with the hemolytic-uremic syndrome under gemcitabine therapy for an adenocarcinoma of the liver. The hemolytic-uremic syndrome and gemcitabine].
Eckel F; Lersch C; Erdmann J; Schmidt B; Schulte-Frohlinde E
Z Gastroenterol; 2000 Jul; 38(7):593-6. PubMed ID: 10965557
[TBL] [Abstract][Full Text] [Related]
15. [Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature].
Desramé J; Duvic C; Bredin C; Béchade D; Artru P; Brézault C; Defuentes G; Poirier JM; Dourthe LM; Coutant G; Chaussade S; de Gramont A; Algayres JP
Rev Med Interne; 2005 Mar; 26(3):179-88. PubMed ID: 15777580
[TBL] [Abstract][Full Text] [Related]
16. Gemcitabine-induced hemolytic-uremic syndrome treated with eculizumab or plasmapheresis: two case reports
.
López Rubio ME; Rodado Martínez R; Illescas ML; Mateo Bosch E; Martinez Díaz M; de la Vara Inesta L; Cabezuelo B; Morales Albuja ME; Lucas Guillén E; Jimeno García L
Clin Nephrol; 2017 Feb; 87 (2017)(2):100-106. PubMed ID: 27879189
[TBL] [Abstract][Full Text] [Related]
17. Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution.
Müller S; Schütt P; Bojko P; Nowrousian MR; Hense J; Seeber S; Moritz T
Ann Hematol; 2005 Feb; 84(2):110-4. PubMed ID: 15340761
[TBL] [Abstract][Full Text] [Related]
18. Livedo racemosa and hemolytic uremic syndrome induced by gemcitabine.
Tognetti L; Garosi G; Rongioletti F; Fimiani M; Rubegni P
Int J Dermatol; 2016 Oct; 55(10):e555-6. PubMed ID: 27125732
[No Abstract] [Full Text] [Related]
19. Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine.
Flombaum CD; Mouradian JA; Casper ES; Erlandson RA; Benedetti F
Am J Kidney Dis; 1999 Mar; 33(3):555-62. PubMed ID: 10070921
[TBL] [Abstract][Full Text] [Related]
20. Hemolytic-uremic syndrome caused by gemcitabine.
Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
